 |
|
|
|
|
BIOTECH/MEDTECH CLUSTER DEVELOPMENT
Today, many societies put special emphasis on exploiting their ability to:
 |
create innovative products |
 |
|
|
build high technology based industries |
|
|
|
secure high content jobs |
to secure the strategic development of their economies and increase the living standard of their population.
Major global metropolitan areas with an inherent tradition of entrepreneurial spirit, creativity among individuals, science institutions performing at an international level and efficient collaboration between public research and industry are capable of realizing such a vision.
As a modern tool to accomplish significant results in high technology areas, regions throughout the world are building clusters and cluster organizations to facilitate such a development.
Through several key projects executed in different parts of the world, Ventac Partners possess in-depth knowledge about how to uncover the potential for establishing a biotech cluster/ industry. We can offer a detailed assessment of:
 |
University research output in the chosen field(s) and how this benchmarks against key centers of the world |
|
|
|
Individual research projects (a large number from which to extract key trends and statistics) and the commercial attributes of each project |
|
|
|
Commercialization attitudes and experience within the university organization(s) |
|
|
|
How well mechanisms and routines for transfer of research projects into commercial settings are developed |
|
|
|
How intellectual property is protected through patenting and otherwise, and to what extend patents strategically meet the requirements of industry |
|
|
|
The availability of qualified human resources to staff new companies and stimulate industrial growth |
|
|
|
Collaborative networks between university, risk capital and industry champions to stimulate commercialization |
|
|
|
The availability of funding and funding programs to stimulate entrepreneurs and industrial development |
Projects are tailored to meet the specific client’s requirements.
Mikael Ørum
Founder of Ventac Partners, Partner, and CEO of
Avexxin AS
Ventac Partners possesses extensive experience in the field of cluster innovation. In 2003-04, we designed and executed a top-down analysis of government, research and education and industry components involved in biomedical innovation in Hong Kong for the purpose of identifying strengths and challenges concerning creation of a biomedical industry cluster in the region.
As a follow-up, in 2008-09 we designed and executed a broad study encompassing 20 universities and research institutions in Hong Kong and Southern China, including reviewing 96 biomedical projects for their global commercial potential.